Kore Private Wealth LLC Gilead Sciences, Inc. Transaction History

Kore Private Wealth LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $625,118 - $709,521	-9,635 Reduced 58.9%	6,722 $488,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $59,837 - $64,558	884 Added 5.71%	16,357 $1.14 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $669,798 - $731,850	10,553 Added 214.49%	15,473 $1.07 Million
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $36,720 - $41,897	612 Added 14.21%	4,920 $318,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $62,258 - $70,940	1,099 Added 34.25%	4,308 $251,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $7,886 - $9,916	127 Added 4.12%	3,209 $203,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $2,821 - $3,276	-39 Reduced 1.25%	3,082 $237,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $95,009 - $121,693	1,517 Added 94.58%	3,121 $233,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $98,838 - $108,719	1,604 New	1,604 $104,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $72,449 - $81,243	-1,171 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $2,626 - $2,942	42 Added 3.72%	1,171 $76,000
Q4 2018 May 23, 2019	BUY	$60.54 - $79.0 $68,349 - $89,191	1,129 New	1,129 $71,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.